lanthionine has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franklin, R; Kuipers, A; Moll, GN; Wagner, E | 1 |
| Abbate, M; Benigni, A; Cassis, P; Cerullo, D; Corna, D; Locatelli, M; Remuzzi, G; Rottoli, D; Villa, S; Zoja, C | 1 |
| Callery, PS; Cooper, AJ; Pinto, JT | 1 |
1 review(s) available for lanthionine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Reversible and irreversible protein glutathionylation: biological and clinical aspects.
Topics: Alanine; Aldehydes; Alzheimer Disease; Apoptosis; Busulfan; Cataract; Cell Cycle; Cystic Fibrosis; Diabetes Mellitus, Type 2; Glutathione; Glutathione Disulfide; Glutathione Transferase; Neoplasms; Oxidation-Reduction; Oxidative Stress; Protein Folding; Proteins; Signal Transduction; Sulfides | 2011 |
2 other study(ies) available for lanthionine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Efficacy of lanthionine-stabilized angiotensin-(1-7) in type I and type II diabetes mouse models.
Topics: Alanine; Angiotensin I; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Insulin; Mice; Mice, Inbred C57BL; Peptide Fragments; Streptozocin; Sulfides; Treatment Outcome | 2019 |
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.
Topics: Alanine; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Half-Life; Humans; Kidney Glomerulus; Lisinopril; Male; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Peptide Fragments; Peptides, Cyclic; Proteinuria; Sulfides | 2019 |